Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eka Nobel, now a core part of Nouryon's Chromatography Solutions, is a premier manufacturer of high-performance silica-based separation media for the global pharmaceutical and biotechnology sectors. The company is best known for its Kromasil product line, which is the industry standard for the large-scale purification of active pharmaceutical ingredients (APIs), including complex peptides, proteins, and small molecules. With a heritage rooted in the industrial legacy of Alfred Nobel, the entity provides critical materials that ensure the purity and efficacy of life-saving medications such as insulin. Eka Nobel operates state-of-the-art manufacturing facilities in Sweden, serving analytical laboratories and industrial production sites worldwide. Its technology platform supports the entire drug development lifecycle, from initial discovery and analysis to commercial-scale downstream processing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eka Nobel.